Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 5th edition, 486 pages

Free download


  Bladder Cancer

  Free Subscription


23.11.2020

1 Aging (Albany NY)
2 Am J Transl Res
1 Ann Palliat Med
1 APMIS
1 Biomed Res Int
1 Bioorg Med Chem
1 BJU Int
1 Bladder Cancer
1 BMC Cancer
1 BMC Med Genet
1 BMC Womens Health
1 Cancer Manag Res
1 Cancer Res
2 Cancers (Basel)
1 Cell Death Dis
1 Clin Genitourin Cancer
1 Clin Oncol (R Coll Radiol)
1 Clinicoecon Outcomes Res
2 Dis Markers
1 Early Hum Dev
1 Eur J Cancer Care (Engl)
1 Eur Radiol
3 Eur Urol
1 Eur Urol Oncol
2 Front Oncol
1 Int Immunopharmacol
1 Int J Environ Res Public Health
1 Int J Mol Sci
1 J Infect Dis
1 J Laparoendosc Adv Surg Tech A
2 J Nanosci Nanotechnol
1 J Nepal Health Res Counc
3 J Urol
2 JAMA
1 JAMA Ophthalmol
1 Med Oncol
3 Medicine (Baltimore)
1 Nat Commun
2 Oncol Rep
1 Oncotarget
4 Sci Rep
1 Surgery
1 Technol Cancer Res Treat
4 Transl Androl Urol
1 Transl Oncol
1 Urol Clin North Am
2 Urol Oncol
2 Urologiia
1 Urology


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Aging (Albany NY)

  1. CHEN M, Zhang R, Lu L, Du J, et al
    LncRNA PVT1 accelerates malignant phenotypes of bladder cancer cells by modulating miR-194-5p/BCLAF1 axis as a ceRNA.
    Aging (Albany NY). 2020;12:22291-22312.
    PubMed         Abstract available


    Am J Transl Res

  2. PENG YL, Wu ZS, Lu HM, Wei WS, et al
    Prognostic significance of tumor-infiltrating immune cells in muscle-invasive bladder cancer.
    Am J Transl Res. 2020;12:6524-6536.
    PubMed         Abstract available

  3. YAN L, Li Q, Sun K, Jiang F, et al
    MiR-4644 is upregulated in plasma exosomes of bladder cancer patients and promotes bladder cancer progression by targeting UBIAD1.
    Am J Transl Res. 2020;12:6277-6289.
    PubMed         Abstract available


    Ann Palliat Med

  4. RABY SEM, Hoskin P, Choudhury A
    The role of palliative radiotherapy in bladder cancer: a narrative review.
    Ann Palliat Med. 2020 Nov 10. pii: apm-20-1347. doi: 10.21037/apm-20-1347.
    PubMed         Abstract available


    APMIS

  5. NADLER N, Kvich L, Bjarnsholt T, Bjerggaard Jensen J, et al
    The discovery of bacterial biofilm in patients with muscle invasive bladder cancer.
    APMIS. 2020 Nov 18. doi: 10.1111/apm.13097.
    PubMed         Abstract available


    Biomed Res Int

  6. ZHAO X, Tang Y, Ren H, Lei Y, et al
    Identification of Prognosis-Related Genes in Bladder Cancer Microenvironment across TCGA Database.
    Biomed Res Int. 2020;2020:9143695.
    PubMed         Abstract available


    Bioorg Med Chem

  7. WANG X, Chen F, Gou S
    Anti-tumor effects and cell motility inhibition of the DN604-gemcitabine combined treatment in human bladder cancer models.
    Bioorg Med Chem. 2020 Nov 7:115858. doi: 10.1016/j.bmc.2020.115858.
    PubMed         Abstract available


    BJU Int

  8. BROOKS NA, Kokorovic A, Xiao L, Matulay JT, et al
    The Obesity Paradox: Defining the impact of Body Mass Index and Diabetes Mellitus for patients with Non-Muscle Invasive Bladder Cancer Treated with Bacillus Calmette-Guerin.
    BJU Int. 2020 Nov 14. doi: 10.1111/bju.15296.
    PubMed         Abstract available


    Bladder Cancer

  9. ANDOLFI C, Bloodworth JC, Papachristos A, Sweis RF, et al
    The Urinary Microbiome and Bladder Cancer: Susceptibility and Immune Responsiveness.
    Bladder Cancer. 2020;6:225-235.
    PubMed         Abstract available


    BMC Cancer

  10. PARKER HG, Dhawan D, Harris AC, Ramos-Vara JA, et al
    RNAseq expression patterns of canine invasive urothelial carcinoma reveal two distinct tumor clusters and shared regions of dysregulation with human bladder tumors.
    BMC Cancer. 2020;20:251.
    PubMed         Abstract available


    BMC Med Genet

  11. JORDAHL KM, Phipps AI, Randolph TW, Tinker LF, et al
    Mediation by differential DNA methylation of known associations between single nucleotide polymorphisms and bladder cancer risk.
    BMC Med Genet. 2020;21:228.
    PubMed         Abstract available


    BMC Womens Health

  12. JHANG S, Chen M, Chen LC
    Concurrent mullerianosis of the urinary bladder and the umbilicus presenting with umbilical bleeding: a rare case report and review of the literature.
    BMC Womens Health. 2020;20:66.
    PubMed         Abstract available


    Cancer Manag Res

  13. LIU J, Yu X, Liu B, Yu H, et al
    Phosphorylated MAPK14 Promotes the Proliferation and Migration of Bladder Cancer Cells by Maintaining RUNX2 Protein Abundance.
    Cancer Manag Res. 2020;12:11371-11382.
    PubMed         Abstract available


    Cancer Res

  14. BUI NHB, Napoli M, Davis AJ, Abbas HA, et al
    Spatiotemporal Regulation of DeltaNp63 by TGFbeta-Regulated miRNAs Is Essential for Cancer Metastasis.
    Cancer Res. 2020;80:2833-2847.
    PubMed         Abstract available


    Cancers (Basel)

  15. SANTHA S, Ling X, Aljahdali IAM, Rasam SS, et al
    Mutant Kras as a Biomarker Plays a Favorable Role in FL118-Induced Apoptosis, Reactive Oxygen Species (ROS) Production and Modulation of Survivin, Mcl-1 and XIAP in Human Bladder Cancer.
    Cancers (Basel). 2020;12.
    PubMed         Abstract available

  16. PAPADAKI V, Asada K, Watson JK, Tamura T, et al
    Two Secreted Proteoglycans, Activators of Urothelial Cell-Cell Adhesion, Negatively Contribute to Bladder Cancer Initiation and Progression.
    Cancers (Basel). 2020;12.
    PubMed         Abstract available


    Cell Death Dis

  17. LAI CH, Xu K, Zhou J, Wang M, et al
    DEPDC1B is a tumor promotor in development of bladder cancer through targeting SHC1.
    Cell Death Dis. 2020;11:986.
    PubMed         Abstract available


    Clin Genitourin Cancer

  18. FISCHER-VALUCK BW, Michalski JM, Harton JG, Birtle A, et al
    Management of Muscle-Invasive Bladder Cancer During a Pandemic: Impact of Treatment Delay on Survival Outcomes for Patients Treated With Definitive Concurrent Chemoradiotherapy.
    Clin Genitourin Cancer. 2020 Jun 22. pii: S1558-7673(20)30144.
    PubMed         Abstract available


    Clin Oncol (R Coll Radiol)

  19. WILSON C, Moseshvili E, Tacey M, Quin I, et al
    Assessment of Intrafraction Motion of the Urinary Bladder Using Magnetic Resonance Imaging (cineMRI).
    Clin Oncol (R Coll Radiol). 2020;32:101-109.
    PubMed         Abstract available


    Clinicoecon Outcomes Res

  20. DOSHI GK, Bhanegaonkar A, Kearney M, Bharmal M, et al
    Treatment Sequencing Patterns in Patients with Metastatic Urothelial Cancer Treated in the Community Practice Setting in the United States: SPEAR-Bladder (Study informing treatment Pathway dEcision in bladder cAnceR).
    Clinicoecon Outcomes Res. 2020;12:645-656.
    PubMed         Abstract available


    Dis Markers

  21. CAO R, Ma B, Wang G, Xiong Y, et al
    An Epithelial-Mesenchymal Transition (EMT) Preoperative Nomogram for Prediction of Lymph Node Metastasis in Bladder Cancer (BLCA).
    Dis Markers. 2020;2020:8833972.
    PubMed         Abstract available

  22. YANG J, Jian Z, Shen P, Bai Y, et al
    Associations between Interleukin-32 Gene Polymorphisms rs12934561 and rs28372698 and Susceptibilities to Bladder Cancer and the Prognosis in Chinese Han Population.
    Dis Markers. 2020;2020:8860445.
    PubMed         Abstract available


    Early Hum Dev

  23. WANG T, Zhang D, Sun K, Wu G, et al
    The second to fourth digit ratio (2D:4D): A risk factor of bladder cancer in men.
    Early Hum Dev. 2020;152:105247.
    PubMed         Abstract available


    Eur J Cancer Care (Engl)

  24. RAMMANT E, Deforche B, Van Hecke A, Verhaeghe S, et al
    Development of a pre- and postoperative physical activity promotion program integrated in the electronic health system of patients with bladder cancer (The POPEYE study): An intervention mapping approach.
    Eur J Cancer Care (Engl). 2020 Nov 17:e13363. doi: 10.1111/ecc.13363.
    PubMed         Abstract available


    Eur Radiol

  25. DELLI PIZZI A, Mastrodicasa D, Marchioni M, Primiceri G, et al
    Bladder cancer: do we need contrast injection for MRI assessment of muscle invasion? A prospective multi-reader VI-RADS approach.
    Eur Radiol. 2020 Nov 19. pii: 10.1007/s00330-020-07473.
    PubMed         Abstract available


    Eur Urol

  26. IYER G, Bochner BH, Van Allen EM, Solit DB, et al
    Re: Russell E.N. Becker, Alexa R. Meyer, Aaron Brant, et al. Clinical Restaging and Tumor Sequencing are Inaccurate Indicators of Response to Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer. Eur Urol. In press. https://doi.org/10.1016/j.eu
    Eur Urol. 2020 Nov 17. pii: S0302-2838(20)30865.
    PubMed        

  27. BECKER REN, Baras A, Bivalacqua TJ
    Reply to Gopa Iyer, Bernard H. Bochner, Eliezer M. Van Allen, David B. Solit, and Jonathan E. Rosenberg's Letter to the Editor re: Russell E.N. Becker, Alexa R. Meyer, Aaron Brant, et al. Clinical Restaging and Tumor Sequencing are Inaccurate Indicato
    Eur Urol. 2020 Nov 17. pii: S0302-2838(20)30864.
    PubMed        

  28. BAKER SC, Mason AS, Southgate J
    Does a Novel Mutagenic Process Target KMT2D Mutation in the Most Common First Event on the Path to Bladder Cancer?
    Eur Urol. 2020 Nov 14. pii: S0302-2838(20)30866.
    PubMed        


    Eur Urol Oncol

  29. BABJUK M
    Unanswered Questions for Bladder Tumours Unresponsive to Bacillus Calmette-Guerin.
    Eur Urol Oncol. 2020;3:341-342.
    PubMed        


    Front Oncol

  30. TAO L, Pan X, Zhang L, Wang J, et al
    Marital Status and Prognostic Nomogram for Bladder Cancer With Distant Metastasis: A SEER-Based Study.
    Front Oncol. 2020;10:586458.
    PubMed         Abstract available

  31. ZUCALI PA, Cordua N, D'Antonio F, Borea F, et al
    Current Perspectives on Immunotherapy in the Peri-Operative Setting of Muscle-Infiltrating Bladder Cancer.
    Front Oncol. 2020;10:568279.
    PubMed         Abstract available


    Int Immunopharmacol

  32. WANG J, Shen C, Dong D, Zhong X, et al
    Identification and verification of an immune-related lncRNA signature for predicting the prognosis of patients with bladder cancer.
    Int Immunopharmacol. 2020 Nov 11:107146. doi: 10.1016/j.intimp.2020.107146.
    PubMed         Abstract available


    Int J Environ Res Public Health

  33. KIM SH, Ryu E, Kim EJ
    A Narrative Inquiry into the Adjustment Experiences of Male Bladder Cancer Survivors with a Neobladder.
    Int J Environ Res Public Health. 2020;17.
    PubMed         Abstract available


    Int J Mol Sci

  34. HULSEN S, Lippolis E, Ferrazzi F, Otto W, et al
    High Stroma T-Cell Infiltration is Associated with Better Survival in Stage pT1 Bladder Cancer.
    Int J Mol Sci. 2020;21.
    PubMed         Abstract available


    J Infect Dis

  35. YAN Y, Zhang H, Jiang C, Ma X, et al
    Human papillomavirus prevalence and integration status in tissue samples of bladder cancer in Chinese population.
    J Infect Dis. 2020 Nov 18. pii: 5986718. doi: 10.1093.
    PubMed         Abstract available


    J Laparoendosc Adv Surg Tech A

  36. ZHU C, Zuo W, Yuan L, Su J, et al
    Comparison of Laparoendoscopic Single-Site and Laparoscopic Radical Cystectomy for Male Patients with Bladder Cancer: Perioperative and Oncologic Outcomes.
    J Laparoendosc Adv Surg Tech A. 2020 Nov 13. doi: 10.1089/lap.2020.0611.
    PubMed         Abstract available


    J Nanosci Nanotechnol

  37. LIU B, Gao X, Han B, Chen G, et al
    Mouse Model to Explore the Therapeutic Effect of Nano-Doxorubicin Drug Delivery System on Bladder Cancer.
    J Nanosci Nanotechnol. 2021;21:914-920.
    PubMed         Abstract available

  38. LIN Y, Shen Z, Tao T, Xu C, et al
    Study on the Effect of Polymer Nano-Loaded Drug System on Bladder Cancer Perfusion.
    J Nanosci Nanotechnol. 2021;21:955-961.
    PubMed         Abstract available


    J Nepal Health Res Counc

  39. POUDEL R, Shah A
    Incidence of Incidental Gall Bladder Cancer and Role of Routine Histopathological Examination in Cholecystectomies Specimens for Benign Disease.
    J Nepal Health Res Counc. 2020;18:547-550.
    PubMed         Abstract available


    J Urol

  40. CHANG SS
    Re: Impact of Adjuvant Chemotherapy in Patients with Adverse Features and Variant Histology at Radical Cystectomy for Muscle-Invasive Carcinoma of the Bladder: Does Histologic Subtype Matter?
    J Urol. 2020;204:1378.
    PubMed        

  41. DE JONG FC, Hoedemaeker RF, Kvikstad V, Mensink JTM, et al
    T1-Substaging of Non-muscle Invasive Bladder Cancer is Associated with BCG-Failure and Improves Patient Stratification at Diagnosis.
    J Urol. 2020 Nov 16:101097JU0000000000001422. doi: 10.1097/JU.0000000000001422.
    PubMed         Abstract available

  42. WANG DS
    Re: Epidural Anesthesia is Associated with Increased Complications in Cystectomy Patients: A NSQIP Analysis.
    J Urol. 2020;204:1072-1073.
    PubMed        


    JAMA

  43. LENIS AT, Lec PM, Chamie K
    Bladder Cancer.
    JAMA. 2020;324:2006.
    PubMed        

  44. LENIS AT, Lec PM, Chamie K, Mshs MD, et al
    Bladder Cancer: A Review.
    JAMA. 2020;324:1980-1991.
    PubMed         Abstract available


    JAMA Ophthalmol

  45. KAPLAN TM, Milman T, Shields CL
    Atypical Conjunctival Lesion Associated With a Bladder Problem.
    JAMA Ophthalmol. 2020;138:204-205.
    PubMed        


    Med Oncol

  46. PARIZI PK, Yarahmadi F, Tabar HM, Hosseini Z, et al
    MicroRNAs and target molecules in bladder cancer.
    Med Oncol. 2020;37:118.
    PubMed         Abstract available


    Medicine (Baltimore)

  47. MEI Y, Zheng J, Xiang P, Liu C, et al
    Prognostic value of the miR-200 family in bladder cancer: A systematic review and meta-analysis.
    Medicine (Baltimore). 2020;99:e22891.
    PubMed         Abstract available

  48. PENG X, Wang J, Li D, Chen X, et al
    Identification of grade-related genes and construction of a robust genomic-clinicopathologic nomogram for predicting recurrence of bladder cancer.
    Medicine (Baltimore). 2020;99:e23179.
    PubMed         Abstract available

  49. GAO L, Xie W, Li K, Huang G, et al
    Primitive neuroectodermal tumor of urinary bladder: A case report and literature review.
    Medicine (Baltimore). 2020;99:e23032.
    PubMed         Abstract available


    Nat Commun

  50. KONG J, Lee H, Kim D, Han SK, et al
    Network-based machine learning in colorectal and bladder organoid models predicts anti-cancer drug efficacy in patients.
    Nat Commun. 2020;11:5485.
    PubMed         Abstract available


    Oncol Rep

  51. ZHANG Z, Chen F, Zhan H, Chen L, et al
    lncRNA CASC9 sponges miR7583p to promote proliferation and EMT in bladder cancer by upregulating TGFbeta2.
    Oncol Rep. 2020 Nov 13. doi: 10.3892/or.2020.7852.
    PubMed         Abstract available

  52. CHEN Y, Xu T, Xie F, Wang L, et al
    Evaluating the biological functions of the prognostic genes identified by the Pathology Atlas in bladder cancer.
    Oncol Rep. 2020 Nov 13. doi: 10.3892/or.2020.7853.
    PubMed         Abstract available


    Oncotarget

  53. MERRILL NM, Vandecan NM, Day KC, Palmbos PL, et al
    MEK is a promising target in the basal subtype of bladder cancer.
    Oncotarget. 2020;11:3921-3932.
    PubMed         Abstract available


    Sci Rep

  54. BOWDEN M, Nadal R, Zhou CW, Werner L, et al
    Transcriptomic analysis of micropapillary high grade T1 urothelial bladder cancer.
    Sci Rep. 2020;10:20135.
    PubMed         Abstract available

  55. ZHU J, Wang H, Ma T, He Y, et al
    Identification of immune-related genes as prognostic factors in bladder cancer.
    Sci Rep. 2020;10:19695.
    PubMed         Abstract available

  56. ZUPPONE S, Assalini C, Minici C, Bertagnoli S, et al
    The anti-tumoral potential of the saporin-based uPAR-targeting chimera ATF-SAP.
    Sci Rep. 2020;10:2521.
    PubMed         Abstract available

  57. PHILYPPOV IB, Sotkis GV, Rock A, Roudbaraki M, et al
    Alterations in detrusor contractility in rat model of bladder cancer.
    Sci Rep. 2020;10:19651.
    PubMed         Abstract available


    Surgery

  58. VUILLERMET C, Meillat H, Manceau G, Creavin B, et al
    Advanced colonic cancer with clinically suspected bladder invasion: Outcomes and prognosis from a multicentric study of 117 patients from the FRENCH research group.
    Surgery. 2020;168:786-792.
    PubMed         Abstract available


    Technol Cancer Res Treat

  59. WANG H, Wu JX, Chen XP, Zhang Q, et al
    Expression and Clinical Significance of MMP-28 in Bladder Cancer.
    Technol Cancer Res Treat. 2020;19:1533033820974017.
    PubMed         Abstract available


    Transl Androl Urol

  60. TAYLOR J, Matulewicz RS
    Multiparametric cystoscopy: opportunities to enhance bladder cancer detection.
    Transl Androl Urol. 2020;9:2302-2304.
    PubMed        

  61. KRIEGMAIR MC, Bolenz C
    Re: "Multiparametric cystoscopy: opportunities to enhance bladder cancer detection".
    Transl Androl Urol. 2020;9:2318-2319.
    PubMed        

  62. HUANG H, Fan X, Zhang X, Xie Y, et al
    LncRNA CARLo-7 facilitates proliferation, migration, invasion, and EMT of bladder cancer cells by regulating Wnt/beta-catenin and JAK2/STAT3 signaling pathways.
    Transl Androl Urol. 2020;9:2251-2261.
    PubMed         Abstract available

  63. DEL GIUDICE F, Campa R, Bicchetti M, De Berardinis E, et al
    Vesical Imaging-Reporting and Data System (VI-RADS) incorporated into bladder cancer clinical practice: what's the perspectives beyond diagnostic accuracy?
    Transl Androl Urol. 2020;9:2320-2322.
    PubMed        


    Transl Oncol

  64. YING H, Fengying S, Feng H, Yanhong W, et al
    Diagnostic value of quantification of circulating free DNA for gall bladder cancer using a chemiluminescence DNA biosensor system based on DNA G-quadruplex/ hemin enzyme.
    Transl Oncol. 2020;14:100928.
    PubMed         Abstract available


    Urol Clin North Am

  65. CAI PY, Khan AI, Scherr DS, Shoag JE, et al
    Robotic Radical Cystectomy in the Contemporary Management of Bladder Cancer.
    Urol Clin North Am. 2021;48:45-50.
    PubMed         Abstract available


    Urol Oncol

  66. NOUHAUD FX, Chakroun M, Lenormand C, Ouzaid I, et al
    Comparison of the prognosis of primary vs. progressive muscle invasive bladder cancer after radical cystectomy: Results from a large multicenter study.
    Urol Oncol. 2020 Nov 16. pii: S1078-1439(20)30424.
    PubMed         Abstract available

  67. HURMUZ P, Ozyigit G, Kilickap S, Esen CSB, et al
    Gemcitabine based trimodality treatment in patients with muscle invasive bladder cancer: May neutrophil lymphocyte and platelet lymphocyte ratios predict outcomes?
    Urol Oncol. 2020 Nov 11. pii: S1078-1439(20)30575.
    PubMed         Abstract available


    Urologiia

  68. KARPOV VK, Kapranov SA, Sharapov BM, Kamalov AA, et al
    [Super-selective embolisation of bladder arteries for treatment of patients with bladder tumors complicated by recurrent macrohematuria].
    Urologiia. 2020;:133-138.
    PubMed         Abstract available

  69. GULIEV BG, Komyakov BK, Bolokotov RR, Al-Attar TK, et al
    [Robot-assisted radical cystectomy with neobladder formation].
    Urologiia. 2020;:54-60.
    PubMed         Abstract available


    Urology

  70. MAGGEN C, Linssen J, Gziri MM, Zola P, et al
    Renal and Bladder Cancer During Pregnancy: A Review of 47 Cases and Literature-based Recommendations for Management.
    Urology. 2020 Oct 22. pii: S0090-4295(20)31271.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: